103 related articles for article (PubMed ID: 15465603)
1. Early administration of IL-12 suppresses EAE through induction of interferon-gamma.
Gran B; Chu N; Zhang GX; Yu S; Li Y; Chen XH; Kamoun M; Rostami A
J Neuroimmunol; 2004 Nov; 156(1-2):123-31. PubMed ID: 15465603
[TBL] [Abstract][Full Text] [Related]
2. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way.
Berghmans N; Dillen C; Heremans H
J Neuroimmunol; 2006 Jul; 176(1-2):63-75. PubMed ID: 16764944
[TBL] [Abstract][Full Text] [Related]
3. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis.
Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T
Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563
[TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Bright JJ; Du C; Coon M; Sriram S; Klaus SJ
J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738
[TBL] [Abstract][Full Text] [Related]
5. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination.
Furlan R; Martino G; Galbiati F; Poliani PL; Smiroldo S; Bergami A; Desina G; Comi G; Flavell R; Su MS; Adorini L
J Immunol; 1999 Sep; 163(5):2403-9. PubMed ID: 10452974
[TBL] [Abstract][Full Text] [Related]
6. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
7. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y
J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
[TBL] [Abstract][Full Text] [Related]
8. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis.
Xiao BG; Ma CG; Xu LY; Link H; Lu CZ
Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713
[TBL] [Abstract][Full Text] [Related]
9. The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma.
Cheng X; Zhao Z; Ventura E; Gran B; Shindler KS; Rostami A
J Neuroimmunol; 2007 Apr; 185(1-2):75-86. PubMed ID: 17320975
[TBL] [Abstract][Full Text] [Related]
10. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively.
Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A
Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323
[TBL] [Abstract][Full Text] [Related]
11. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
Suryani S; Sutton I
J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458
[TBL] [Abstract][Full Text] [Related]
12. Exploiting genotypic differences to identify genes important for EAE development.
Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S
J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ghazavi A; Mosayebi G
Phytother Res; 2012 Jan; 26(1):34-8. PubMed ID: 21538630
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12.
Leonard JP; Waldburger KE; Schaub RG; Smith T; Hewson AK; Cuzner ML; Goldman SJ
Crit Rev Immunol; 1997; 17(5-6):545-53. PubMed ID: 9419442
[TBL] [Abstract][Full Text] [Related]
15. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment.
Wang J; Wang G; Sun B; Li H; Mu L; Wang Q; Li G; Shi L; Jin L; Kostulas N
J Autoimmun; 2008 Jun; 30(4):222-9. PubMed ID: 17997278
[TBL] [Abstract][Full Text] [Related]
17. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis.
Li J; Gran B; Zhang GX; Rostami A; Kamoun M
J Neurol Sci; 2005 May; 232(1-2):3-9. PubMed ID: 15850576
[TBL] [Abstract][Full Text] [Related]
18. Ingested (oral) alpha-MSH inhibits acute EAE.
Brod SA; Hood ZM
J Neuroimmunol; 2008 Jan; 193(1-2):106-12. PubMed ID: 18037504
[TBL] [Abstract][Full Text] [Related]
19. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Zhou R; Zhou Y; Dong JR; He PL; Wan H; Li YC; Yang YF; Zuo JP
J Neuroimmunol; 2006 Jun; 175(1-2):142-51. PubMed ID: 16712960
[TBL] [Abstract][Full Text] [Related]
20. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
